A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer *
- 1 March 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (3) , 404-412
- https://doi.org/10.1016/0959-8049(95)00014-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- 4-hydroxyandrostenedione: A new treatment for postmenopausal patients with breast cancerEuropean Journal Of Cancer, 1992
- Endocrine therapy for advanced breast cancer: A reviewBreast Cancer Research and Treatment, 1992
- A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Megestrol acetate versus aminoglutethimide for metastatic breast cancerBreast Cancer Research and Treatment, 1989
- Aromatase inhibitors in the treatment of advanced breast cancerCancer Treatment Reviews, 1989
- Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapyEuropean Journal of Cancer and Clinical Oncology, 1989
- Mechanisms of Action of Aminoglutethimide as Endocrine Therapy of Breast CancerDrugs, 1988
- Aminoglutethimide in advanced breast cancer: Clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/dayEuropean Journal of Cancer and Clinical Oncology, 1985
- Endogenous oestradiol-17β concentration in breast tumours determined by mass fragmentography and by radioimmunoassay: Relationship to receptor contentPublished by Elsevier ,1980
- Assessment of response to therapy in advanced breast cancerPublished by Elsevier ,1977